Skip to main content
logo
CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.640
-0.020 (-0.75%)
Jul 27, 2026, 1:16 PM EDT - Market open

CervoMed Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.094.019.747.14--
Revenue Growth
-77.56%-58.86%36.29%---
Gross Profit
2.094.019.747.14--
Operating Income
-31.1-28.29-18.23-7.81-3.48-24.68
Net Income
-30.04-26.97-16.29-2.17-5.8-24.1
Earnings Per Share
-3.42-2.98-2.02-0.82-11.20-18.57
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
12.9220.8638.927.7922.5237.31
Total Debt
000000
Net Cash (Debt)
12.9220.8638.927.7922.5237.31
Net Cash Growth
-63.33%-46.39%399.46%-65.40%-39.64%103.16%
Net Cash Per Share
1.402.314.822.9343.4751.99

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-27.57-23.45-16.53-7.45-2.57-14.5
Free Cash Flow
-27.57-23.45-16.53-7.45-2.57-14.5
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-1488.86%-706.22%-187.18%-109.35%--
Pretax Margin
-1457.96%-673.06%-167.29%-30.40%--
Profit Margin
-1437.83%-673.06%-167.29%-30.40%--
FCF Margin
-1319.95%-585.30%-169.76%-104.27%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.3518.242.096.06--